エピジェネティクスの世界市場レポート 2025年

エピジェネティクスの市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年にはCAGR22.7％で290億8,000万米ドルに成長します。予測期間の成長は、エピジェネティック医薬品開発、環境衛生におけるエピジェネティクス、精密農業におけるエピジェネティクス、規制支援、患者意識およびアドボカシーに起因します。予測期間における主な動向は、エピトランスクリプトミクス、シングルセルエピゲノミクス、エピジェネティック編集、エピジェネティックバイオマーカー、老化・長寿研究、マイクロバイオーム-エピゲノム相互作用などです。

がんやその他の疾患の有病率の上昇が、エピジェネティクス市場の成長を大きく促進しています。疾病の発生率が増加するにつれて、エピジェネティクスの需要も増加します。例えば、2024年5月、米国を拠点とする政府機関である国立がん研究所（NCI）は、2022年に約2,000万人のがん患者が新たに記録され、その結果、この病気に関連して約970万人が死亡したと報告しました。予測によれば、2040年までに新規のがん罹患者数は年間2,990万人に増加し、がん関連死は1,530万人に達します。さらに、米国疾病予防管理センター（CDC）の推計によると、米国では毎年約65万9,000人が心臓病で死亡しています。がんやその他の疾患の有病率の増加により、遺伝子の変化を検査し理解することが必要となり、必然的にエピジェネティクスの使用と需要が高まっています。したがって、がんやその他の疾患の有病率の増加は、今後数年間、エピジェネティクス市場を牽引すると予想されます。

エピジェネティクス市場は、精密医療への注目が高まっていることから成長が見込まれています。精密医療とは、より効果的な疾病管理と治療のために、個人の遺伝的、環境的、ライフスタイル的情報に基づいて医療アプローチを調整することです。エピジェネティクスの領域では、精密医療は個人のエピジェネティックプロファイルと遺伝子データを利用して個別化ヘルスケア戦略を策定します。個別化医療連合（Personalized Medicine Coalition）によると、2022年に食品医薬品局（FDA）の医薬品評価研究センター（Center for Drug Evaluation and Research）は37の治療用新規分子体を承認し、そのうち34％が個別化医薬品に分類されました。このように精密医療が重視されていることが、エピジェネティクス市場の拡大に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のエピジェネティクス市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のエピジェネティクス市場の成長率分析
• 世界のエピジェネティクス市場の実績：規模と成長、2019～2024年
• 世界のエピジェネティクス市場の予測：規模と成長、2024～2029年、2034年
• 世界のエピジェネティクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のエピジェネティクス市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 試薬
• 酵素
• 機器
• キット
• 世界のエピジェネティクス市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• DNAメチル化
• ヒストンメチル化
• ヒストンアセチル化
• 大型ノンコーディングRNA
• マイクロRNA修飾
• クロマチン構造
• 世界のエピジェネティクス市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 腫瘍学
• 代謝性疾患
• 発生生物学
• 免疫学
• 心血管疾患
• その他の用途
• 世界のエピジェネティクス市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 学術研究機関
• 製薬・バイオテクノロジー企業
• 契約研究機関
• その他のエンドユーザー
• 世界のエピジェネティクス市場：試薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• DNAメチル化試薬
• ヒストン修飾試薬
• RNA修飾試薬
• 酵素
• 世界のエピジェネティクス市場：酵素のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• DNAメチルトランスフェラーゼ
• ヒストンアセチルトランスフェラーゼ
• ヒストン脱アセチル化酵素
• その他のエピジェネティック酵素
• 世界のエピジェネティクス市場：機器のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• シーケンサー
• PCRマシン
• マイクロアレイプラットフォーム
• 質量分析計
• 世界のエピジェネティクス市場：キットのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• DNAメチル化キット
• クロマチン免疫沈降（ChIP）キット
• RNA-Seqキット
• 亜硫酸水素塩変換キット

第7章 地域別・国別分析

• 世界のエピジェネティクス市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界のエピジェネティクス市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• エピジェネティクス市場：競合情勢
• エピジェネティクス市場：企業プロファイル
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • Merck Millipore Overview, Products and Services, Strategy and Financial Analysis
  • Active Motif Overview, Products and Services, Strategy and Financial Analysis
  • Abcam PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Qiagen NV
• Diagenode SA
• CellCentric Ltd.
• Chroma Medicine Inc.
• Constellation Pharmaceuticals Inc.
• Domainex Ltd.
• Eisai Co. Ltd.
• Epigen Biosciences Inc.
• EpigenDx Inc.
• Epigenomics AG
• Epizyme Inc.
• Gilead Sciences Inc.
• GlaxoSmithKline plc
• Janssen Pharmaceuticals Inc.
• Locus Biosciences Inc.

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

• エピジェネティクス市場2029年-最も新しい機会を提供する国
• エピジェネティクス市場2029年-最も新しい機会を提供するセグメント
• エピジェネティクス市場2029年-成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Epigenetics refers to changes in gene activity transmitted to younger cells without modifying the DNA sequence. These natural and necessary processes are vital for the functioning of many organisms, but anomalies can lead to disorders such as various types of cancer, reproductive illnesses, and cardiovascular diseases. Epigenetics plays a crucial role in the early detection of certain cancers.

The primary products employed in the epigenetics market include reagents, enzymes, instruments, and kits. Reagents are compounds or substances used for chemical analysis or epigenetic testing. Technologies utilized in epigenetics encompass DNA methylation, histone methylation, histone acetylation, large noncoding RNA, microRNA modification, and chromatin structures. Applications span oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other fields. Epigenetic tools find applications in academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and various other end-user segments.

The epigenetics market research report is one of a series of new reports from The Business Research Company that provides epigenetics market statistics, including epigenetics industry global market size, regional shares, competitors with an epigenetics market share, detailed epigenetics market segments, market trends and opportunities, and any further data you may need to thrive in the epigenetics industry. This epigenetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The epigenetics market size has grown exponentially in recent years. It will grow from $10.65 billion in 2024 to $12.83 billion in 2025 at a compound annual growth rate (CAGR) of 20.4%. The growth in the historic period can be attributed to increased research funding, rise in incidence of chronic diseases, personalized medicine, cancer research, aging population.

The epigenetics market size is expected to see exponential growth in the next few years. It will grow to $29.08 billion in 2029 at a compound annual growth rate (CAGR) of 22.7%. The growth in the forecast period can be attributed to epigenetic drug development, epigenetics in environmental health, epigenetics in precision agriculture, regulatory support, patient awareness and advocacy. Major trends in the forecast period include epitranscriptomics, single-cell epigenomics, epigenetic editing, epigenetic biomarkers, aging and longevity research, microbiome-epigenome interactions.

The rising prevalence of cancer and other diseases is significantly propelling the growth of the epigenetics market. As the incidence of diseases increases, so does the demand for epigenetics. For example, in May 2024, the National Cancer Institute (NCI), a U.S.-based government agency, reported that nearly 20 million new cancer cases were documented in 2022, resulting in approximately 9.7 million deaths related to the disease. Projections suggest that by 2040, the annual incidence of new cancer cases will rise to 29.9 million, with cancer-related deaths reaching 15.3 million. Additionally, the Centers for Disease Control and Prevention (CDC) estimates that around 659,000 people in the United States die from heart disease each year. The increasing prevalence of cancer and other diseases necessitates testing and understanding the genetic modifications that occur, which will inevitably boost the usage and demand for epigenetics. Therefore, the growing prevalence of cancer and other diseases is expected to drive the epigenetics market in the coming years.

The epigenetics market is expected to experience growth due to the increasing focus on precision medicine. Precision medicine involves tailoring medical approaches based on an individual's genetic, environmental, and lifestyle information for more effective disease management and treatment. In the realm of epigenetics, precision medicine utilizes individual epigenetic profiles and genetic data to formulate personalized healthcare strategies. In 2022, the Food and Drug Administration's Center for Drug Evaluation and Research approved 37 new molecular entities, with 34% of therapeutic new molecular entities classified as personalized medicines, according to the Personalized Medicine Coalition. This emphasis on precision medicine is contributing to the expansion of the epigenetics market.

Leading companies in the epigenetics market are concentrating on developing technologically advanced solutions, such as DNA sequencing methods, to enhance precision medicine and improve disease understanding and treatment outcomes. DNA sequencing methods are techniques that determine the order of nucleotides in a DNA molecule, allowing for detailed genetic analysis. This information is vital for identifying genetic variations associated with diseases and advancing precision medicine. For example, in March 2023, Illumina Inc., a U.S.-based biotechnology company, introduced Illumina Complete Long Read Technology, which facilitates both long-read and short-read sequencing on a single instrument, significantly improving versatility in genomic research. By reducing DNA input requirements and streamlining the workflow, this technology simplifies the library preparation process, making it more accessible for challenging samples. It also achieves high accuracy in variant calling, providing reliable data that is essential for comprehensive genomic analysis.

Leading companies in the epigenetics market are increasingly incorporating artificial intelligence (AI)-driven analytics into their operations to gain a competitive advantage. AI-driven analytics involves utilizing artificial intelligence technologies to automatically analyze and interpret large volumes of data. For example, in July 2023, FOXO Technologies, a US-based company, introduced Bioinformatics Services aimed at revolutionizing epigenetic data analysis. These services offer a versatile platform with advanced data solutions tailored to meet the specific needs of clients in academia, healthcare, and pharmaceutical research. FOXO's innovative suite of bioinformatic tools aims to enhance the speed and accuracy of data processing, analysis, and interpretation, facilitating quicker discoveries and advancing understanding of complex diseases.

In August 2022, Ipsen Biopharmaceuticals, Inc., a U.S.-based pharmaceutical company that specializes in developing and commercializing medicines for three therapeutic areas, acquired Epizyme, Inc. for $247 million. Through this acquisition, Ipsen Biopharmaceuticals, Inc. aims to enhance its oncology portfolio, broaden its pipeline with innovative treatments, and strengthen its market position in cancer care. Epizyme, Inc., also a U.S.-based commercial company, focuses on creating innovative therapies based on epigenetics.

Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the global epigenetics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the epigenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The epigenetics market includes revenues earned by entities methylation, acetylation, phosphorylation, ubiquitylation, and sumolyation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Epigenetics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on epigenetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for epigenetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The epigenetics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Reagents; Enzymes; Instruments; Kits
• 2) By Technology: DNA Methylation; Histone Methylation; Histone Acetylation; Large Noncoding RNA; MicroRNA Modification; Chromatin Structures
• 3) By Application: Oncology; Metabolic Diseases; Developmental Biology; Immunology; Cardiovascular Diseases; Other Applications
• 4) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Other End Users
• Subsegments:
• 1) By Reagents: DNA Methylation Reagents; Histone Modification Reagents; RNA Modifications Reagents; Enzymes
• 2) By Enzymes: DNA Methyltransferases; Histone Acetyltransferases; Histone Deacetylases; Other Epigenetic Enzymes
• 3) By Instruments: Sequencers; PCR Machines; Microarray Platforms; Mass Spectrometers
• 4) By Kits: DNA Methylation Kits; Chromatin Immunoprecipitation (ChIP) Kits; RNA-Seq Kits; Bisulfite Conversion Kits
• Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific; Merck Millipore; Active Motif; Abcam PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Epigenetics Market Characteristics

3. Epigenetics Market Trends And Strategies

4. Epigenetics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Epigenetics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Epigenetics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Epigenetics Market Growth Rate Analysis
• 5.4. Global Epigenetics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Epigenetics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Epigenetics Total Addressable Market (TAM)

6. Epigenetics Market Segmentation

• 6.1. Global Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents
• Enzymes
• Instruments
• Kits
• 6.2. Global Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Methylation
• Histone Methylation
• Histone Acetylation
• Large Noncoding RNA
• MicroRNA Modification
• Chromatin Structures
• 6.3. Global Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Metabolic Diseases
• Developmental Biology
• Immunology
• Cardiovascular Diseases
• Other Applications
• 6.4. Global Epigenetics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Other End Users
• 6.5. Global Epigenetics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Methylation Reagents
• Histone Modification Reagents
• RNA Modifications Reagents
• Enzymes
• 6.6. Global Epigenetics Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Methyltransferases
• Histone Acetyltransferases
• Histone Deacetylases
• Other Epigenetic Enzymes
• 6.7. Global Epigenetics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sequencers
• PCR Machines
• Microarray Platforms
• Mass Spectrometers
• 6.8. Global Epigenetics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Methylation Kits
• Chromatin Immunoprecipitation (ChIP) Kits
• RNA-Seq Kits
• Bisulfite Conversion Kits

7. Epigenetics Market Regional And Country Analysis

• 7.1. Global Epigenetics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Epigenetics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Epigenetics Market

• 8.1. Asia-Pacific Epigenetics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Epigenetics Market

• 9.1. China Epigenetics Market Overview
• 9.2. China Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Epigenetics Market

• 10.1. India Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Epigenetics Market

• 11.1. Japan Epigenetics Market Overview
• 11.2. Japan Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Epigenetics Market

• 12.1. Australia Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Epigenetics Market

• 13.1. Indonesia Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Epigenetics Market

• 14.1. South Korea Epigenetics Market Overview
• 14.2. South Korea Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Epigenetics Market

• 15.1. Western Europe Epigenetics Market Overview
• 15.2. Western Europe Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Epigenetics Market

• 16.1. UK Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Epigenetics Market

• 17.1. Germany Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Epigenetics Market

• 18.1. France Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Epigenetics Market

• 19.1. Italy Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Epigenetics Market

• 20.1. Spain Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Epigenetics Market

• 21.1. Eastern Europe Epigenetics Market Overview
• 21.2. Eastern Europe Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Epigenetics Market

• 22.1. Russia Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Epigenetics Market

• 23.1. North America Epigenetics Market Overview
• 23.2. North America Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Epigenetics Market

• 24.1. USA Epigenetics Market Overview
• 24.2. USA Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Epigenetics Market

• 25.1. Canada Epigenetics Market Overview
• 25.2. Canada Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Epigenetics Market

• 26.1. South America Epigenetics Market Overview
• 26.2. South America Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Epigenetics Market

• 27.1. Brazil Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Epigenetics Market

• 28.1. Middle East Epigenetics Market Overview
• 28.2. Middle East Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Epigenetics Market

• 29.1. Africa Epigenetics Market Overview
• 29.2. Africa Epigenetics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Epigenetics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Epigenetics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Epigenetics Market Competitive Landscape And Company Profiles

• 30.1. Epigenetics Market Competitive Landscape
• 30.2. Epigenetics Market Company Profiles
  • 30.2.1. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck Millipore Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Active Motif Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Abcam PLC Overview, Products and Services, Strategy and Financial Analysis

31. Epigenetics Market Other Major And Innovative Companies

• 31.1. Qiagen NV
• 31.2. Diagenode SA
• 31.3. CellCentric Ltd.
• 31.4. Chroma Medicine Inc.
• 31.5. Constellation Pharmaceuticals Inc.
• 31.6. Domainex Ltd.
• 31.7. Eisai Co. Ltd.
• 31.8. Epigen Biosciences Inc.
• 31.9. EpigenDx Inc.
• 31.10. Epigenomics AG
• 31.11. Epizyme Inc.
• 31.12. Gilead Sciences Inc.
• 31.13. GlaxoSmithKline plc
• 31.14. Janssen Pharmaceuticals Inc.
• 31.15. Locus Biosciences Inc.

32. Global Epigenetics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Epigenetics Market

34. Recent Developments In The Epigenetics Market

35. Epigenetics Market High Potential Countries, Segments and Strategies

• 35.1 Epigenetics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Epigenetics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Epigenetics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer